PET/computed tomography transformation of oncology: Kidney and urinary tract cancers

Renal cell carcinoma (RCC) and urothelial carcinoma are two of the most common genitourinary malignancies. 2-deoxy-2-[¹⁸F]fluoro-d-glucose can play an important role in the evaluation of these patients. The shift in molecular imaging to focus on specific ligand-receptor interactions should provide novel diagnostic and therapeutic opportunities in genitourinary malignancies. Once the rising use of artificial intelligence is factored in, the ability to obtain the imaging biomarkers associated with treatment selection, response assessment, and overall patient prognostication will only improve.